Not Yet Recruiting
OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition
NCT05425576
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States